Greenwood Capital Associates LLC Gsk PLC Transaction History

Greenwood Capital Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $111,516 - $126,686	2,652 Added 8.29%	34,640 $1.51 Million
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $247,173 - $293,314	6,144 Added 23.77%	31,988 $1.39 Million
Q4 2021 Feb 03, 2022	BUY	$38.88 - $45.31 $140,590 - $163,840	3,616 Added 16.27%	25,844 $1.14 Million
Q3 2021 Oct 27, 2021	BUY	$38.79 - $43.16 $295,579 - $328,879	7,620 Added 52.16%	22,228 $849,000
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $533,484 - $605,647	14,608 New	14,608 $582,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.